FXRHSD17B13 modulator 1, identified by the CAS number 3067566-36-0, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular structure, solubility, and stability may not be widely documented, compounds of this nature typically exhibit properties that allow them to interact selectively with biological targets, potentially modulating pathways related to diseases. The designation as a "modulator" suggests that it may influence the activity of proteins or enzymes, possibly impacting metabolic processes or signaling pathways. Additionally, compounds like FXRHSD17B13 modulator 1 are often evaluated for their pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are crucial for determining their efficacy and safety in clinical settings. As research progresses, more detailed information regarding its mechanism of action, therapeutic potential, and safety profile may become available, contributing to the understanding of its role in drug development.

FXRHSD17B13 modulator 1

3067566-36-0: FXRHSD17B13 modulator 1, identified by the CAS number 3067566-36-0, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular structure, solubility, and stability may not be widely documented, compounds of this nature typically exhibit properties that allow them to interact selectively with biological targets, potentially modulating pathways related to diseases. The designation as a "modulator" suggests that it may influence the activity of proteins or enzymes, possibly impacting metabolic processes or signaling pathways. Additionally, compounds like FXRHSD17B13 modulator 1 are often evaluated for their pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are crucial for determining their efficacy and safety in clinical settings. As research progresses, more detailed information regarding its mechanism of action, therapeutic potential, and safety profile may become available, contributing to the understanding of its role in drug development.

<p>FXR/HSD17B13 modulator 1 (compound 6) is an effective modulator of FXR/HSD17B13, playing a significant role in studies related to metabolic dysfunction-associated steatohepatitis (MASH).</p>

CAS 3067566-36-0

FXRHSD17B13 modulator 1

FXR/HSD17B13 modulator 1

Ref: TM-T204314